Cargando…
Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620590/ https://www.ncbi.nlm.nih.gov/pubmed/37021525 http://dx.doi.org/10.3324/haematol.2022.282637 |
| _version_ | 1785130238941855744 |
|---|---|
| author | Niswander, Lisa M. Chung, Perry Diorio, Caroline Tasian, Sarah K |
| author_facet | Niswander, Lisa M. Chung, Perry Diorio, Caroline Tasian, Sarah K |
| author_sort | Niswander, Lisa M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10620590 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106205902023-11-03 Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax Niswander, Lisa M. Chung, Perry Diorio, Caroline Tasian, Sarah K Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-04-06 /pmc/articles/PMC10620590/ /pubmed/37021525 http://dx.doi.org/10.3324/haematol.2022.282637 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Niswander, Lisa M. Chung, Perry Diorio, Caroline Tasian, Sarah K Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax |
| title | Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax |
| title_full | Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax |
| title_fullStr | Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax |
| title_full_unstemmed | Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax |
| title_short | Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax |
| title_sort | clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620590/ https://www.ncbi.nlm.nih.gov/pubmed/37021525 http://dx.doi.org/10.3324/haematol.2022.282637 |
| work_keys_str_mv | AT niswanderlisam clinicalresponsesinpediatricpatientswithrelapsedrefractoryleukemiatreatedwithazacitidineandvenetoclax AT chungperry clinicalresponsesinpediatricpatientswithrelapsedrefractoryleukemiatreatedwithazacitidineandvenetoclax AT dioriocaroline clinicalresponsesinpediatricpatientswithrelapsedrefractoryleukemiatreatedwithazacitidineandvenetoclax AT tasiansarahk clinicalresponsesinpediatricpatientswithrelapsedrefractoryleukemiatreatedwithazacitidineandvenetoclax |